Complex incentives drive macular degeneration prescription decisions
Tuesday, February 3, 2015 - 08:30
in Health & Medicine
Two drugs that treat macular degeneration are practically interchangeable — except for the price. Ranibizumab costs up to $2,000 per dose, while bevacizumab is $50 per dose. Researchers at the […]